Tommy G. Thompson - 26 Jun 2021 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role: Director
Signature: /s/ John S. Hess, Jr. under Power of Attorney
Issuer symbol: UTHR
Transactions as of: 26 Jun 2021
Net transactions value: $0
Form type: 4
Filing time: 29 Jun 2021, 16:39:09 UTC
Previous filing: 18 May 2021
Next filing: 02 Jul 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	UTHR	Common Stock	Options Exercise	$0	+1,680	+35%	$0.000000	6,520	26 Jun 2021	Direct	F1
holding	UTHR	Common Stock						5,800	26 Jun 2021	By Family LLC
holding	UTHR	Common Stock						8,200	26 Jun 2021	By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	UTHR	Restricted Stock Units	Options Exercise	$0	-1,680	-100%	$0.000000^*	0	26 Jun 2021	Common Stock	1,680	$0.000000	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares received upon vesting of restricted stock units on June 26, 2021. Restricted stock units converted on a one-for-one basis into shares of common stock.
F2	Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
F3	Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.